Stocks / GRCE

Grace Therapeutics, Inc. (GRCE)

No Active Signal

Key Metrics

Current Price $4.67
Intrinsic Value $—
Margin of Safety —%
ROIC —%
Debt / Equity —
Sector Healthcare

AI Analysis

AI analysis not yet available for this ticker.

Related — Healthcare

BTMD
biote Corp.
MoS: 64.5%
CPRX
Catalyst Pharmaceuticals, Inc.
MoS: 43.2%
DOCS
Doximity, Inc.
MoS: 46.6%
EMBC
Embecta Corp.
MoS: 67.4%
GILD
Gilead Sciences, Inc.
MoS: 45.2%
INCY
Incyte Corporation
MoS: 18.5%
IRWD
Ironwood Pharmaceuticals, Inc.
MoS: 77.1%
MRK
Merck & Co., Inc.
MoS: 35.6%

Get alerts for GRCE

Receive signal changes and deep value alerts for Grace Therapeutics, Inc..